1. Home
  2. OC vs GKOS Comparison

OC vs GKOS Comparison

Compare OC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

HOLD

Current Price

$144.41

Market Cap

12.0B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$181.46

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OC
GKOS
Founded
1938
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
10.9B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
OC
GKOS
Price
$144.41
$181.46
Analyst Decision
Buy
Strong Buy
Analyst Count
11
12
Target Price
$145.27
$126.92
AVG Volume (30 Days)
776.9K
761.2K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
2.61%
N/A
EPS Growth
N/A
N/A
EPS
1.50
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
N/A
$23.32
Revenue Next Year
$3.72
$27.43
P/E Ratio
$95.79
N/A
Revenue Growth
N/A
32.33
52 Week Low
$97.53
$73.16
52 Week High
$159.91
$191.62

Technical Indicators

Market Signals
Indicator
OC
GKOS
Relative Strength Index (RSI) 43.79 60.38
Support Level $135.25 $175.04
Resistance Level $145.52 $184.00
Average True Range (ATR) 3.87 6.01
MACD -1.51 -1.59
Stochastic Oscillator 8.02 39.63

Price Performance

Historical Comparison
OC
GKOS

About OC Owens Corning Inc New

Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: